Conference call

Third quarter results for 2018 to be presented November 15. View details



Clinical pipeline

View our pipeline and pre-clinical partnered programs. Read more

Dual-hormone pump

Learn more about the iLet™ from our partner Beta Bionics. View video

Meet 3 SBS patients

Learn more about Short Bowel Syndrome (SBS) from three Danish patients. View video


Upcoming events


Our research

Applying our peptide platform to specialty disease areas to invent novel therapies.
Read more


Late-stage pipeline

Advancing fully owned development programs with Phase 3 in two rare disease programs. See our pipeline

About Zealand

Get a brief overview on Zealand and learn more about our company. Read more


Shareholder portal

As a shareholder, you can access a wide range of investor information.
Read more

The impact of severe hypoglycemia

Read about the ready-to-use dasiglucagon hypo pen

A daily struggle to live
with SBS

Read about glepaglutide for short bowel disease

Subscribe to
Zealand news

Subscribe and get Zealand news